ArticleThe Journal of biological chemistry

mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.

Roberta L Beauchamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.